These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15347128)

  • 1. Measurement of aortic blood flow by magnetic resonance below and above the origin of the coronary arteries in postmenopausal hormone replacement therapy.
    Sørensen MB; Fritz-Hansen T; Jensen HH; Pedersen AT; Ottesen B
    J Cardiovasc Magn Reson; 2004; 6(3):637-44. PubMed ID: 15347128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
    Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
    Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
    Borgfeldt C; Li C; Samsioe G
    Climacteric; 2004 Mar; 7(1):78-85. PubMed ID: 15259286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE; Eilertsen AL; Goeman J; Olstad OK; Ovstebø R; Kierulf P; Mowinckel MC; Skretting G; Sandset PM
    Thromb Res; 2012 Jul; 130(1):45-51. PubMed ID: 22217510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose hormone therapy and carbohydrate metabolism.
    Li C; Samsioe G; Borgfeldt C; Bendahl PO; Wilawan K; Aberg A
    Fertil Steril; 2003 Mar; 79(3):550-5. PubMed ID: 12620438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement.
    Sørensen MB; Fritz-Hansen T; Jensen HH; Pedersen AT; Højgaard L; Ottesen B
    Am J Obstet Gynecol; 2001 Jan; 184(2):41-7. PubMed ID: 11174477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
    Paoletti AM; Cagnacci A; Di Carlo C; Orrù MM; Neri M; D'Alterio MN; Melis GB
    Gynecol Endocrinol; 2015 May; 31(5):384-7. PubMed ID: 25703254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A; Ma H; Bjørndal H; Ursin G
    Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath-hold MR measurements of blood flow velocity in internal mammary arteries and coronary artery bypass grafts.
    Sakuma H; Globits S; O'Sullivan M; Shimakawa A; Bernstein MA; Foo TK; Amidon TM; Takeda K; Nakagawa T; Higgins CB
    J Magn Reson Imaging; 1996; 6(1):219-22. PubMed ID: 8851431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of coronary artery volume flow rate using fast velocity-encoded cine MR imaging.
    Sakuma H; Saeed M; Takeda K; Wendland MF; Schwitter J; Szolar DH; Derugin N; Shimakawa A; Foo TK; Higgins CB
    AJR Am J Roentgenol; 1997 May; 168(5):1363-7. PubMed ID: 9129446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
    Panay N; Ylikorkala O; Archer DF; Gut R; Lang E
    Climacteric; 2007 Apr; 10(2):120-31. PubMed ID: 17453860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.